Medicus Pharma Eyes Pivotal Trial for Novel Skin Cancer Therapy as Phase 2 Enrollment Progresses | TSX-V:MDCX, NASDAQ:MDCX

Proactive InvestorsDec 3 03:44

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

newsfileDec 2 20:30

Medicus Pharma Ltd. Expands With Strategic Takeover

TipRanksNov 25 21:30

6-K: Report of foreign private issuer (related to financial reporting)

SECNov 25 21:02 · Announcements

Medicus Pharma Unveils Ex-GSK and Pfizer Senior as Chief Medical Officer | TSX-V:MDCX, NASDAQ:MDCX

Proactive InvestorsNov 18 21:44

Leadership Changes at Medicus Pharma Ltd

TipRanksNov 18 21:10